Daniel Clark
Stock Analyst at Leerink Partners
(2.89)
# 1,724
Out of 4,981 analysts
7
Total ratings
80%
Success rate
21.36%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDXX IDEXX Laboratories | Maintains: Outperform | $580 → $600 | $649.11 | -7.57% | 3 | Jul 17, 2025 | |
| ZTS Zoetis | Downgrades: Market Perform | $180 → $155 | $146.92 | +5.50% | 2 | Jul 17, 2025 | |
| ELAN Elanco Animal Health | Upgrades: Outperform | $18 | $18.48 | -2.57% | 2 | Jul 17, 2025 |
IDEXX Laboratories
Jul 17, 2025
Maintains: Outperform
Price Target: $580 → $600
Current: $649.11
Upside: -7.57%
Zoetis
Jul 17, 2025
Downgrades: Market Perform
Price Target: $180 → $155
Current: $146.92
Upside: +5.50%
Elanco Animal Health
Jul 17, 2025
Upgrades: Outperform
Price Target: $18
Current: $18.48
Upside: -2.57%